RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Trimetazidine in cardiovascular medicine
2019 Marzilli, M.; Vinereanu, D.; Lopaschuk, G.; Chen, Y.; Dalal, J. J.; Danchin, N.; Etriby, E.; Ferrari, R.; Gowdak, L. H.; Lopatin, Y.; Milicic, D.; Parkhomenko, A.; Pinto, F.; Ponikowski, P.; Seferovic, P.; Rosano, G. M. C.
Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium?
file con accesso da definire1998 Ceconi, Claudio; S., Curello; T., Bachetti; A., Corti; Ferrari, Roberto
Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study.
file con accesso da definire2005 Marco, Valgimigli; Ceconi, Claudio; Malagutti, Patrizia; Elisa, Merli; Olga, Soukhomovskaia; Gloria, Francolini; Giordano, Cicchitelli; Adriana, Olivares; Giovanni, Parrinello; Gianfranco, Percoco; Gabriele, Guardigli; Donato, Mele; Roberto, Pirani; Ferrari, Roberto
Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial
2007 Valgimigli, M; Bolognese, L; Anselmi, M; Campo, Gianluca Calogero; Rodriguez, Ae; de Cesare, N; Cohen, Dj; Sheiban, I; Colangelo, S; Pasquetto, G; Hamon, M; Vranckx, P; Ferrario, M; Prati, F; Agostoni, P; Malagutti, P; Arcozzi, C; Parrinello, G; Vassanelli, C; Ferrari, Roberto; Percoco, G.
Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study
2007 Valgimigli, M; Campo, Gianluca Calogero; Arcozzi, C; Malagutti, P; Carletti, R; Ferrari, F; Barbieri, D; Parrinello, G; Percoco, G; Ferrari, Roberto
Two-year outcomes after first- or second-generation drug-eluting stent implantation in patients with in-stent restenosis. A PRODIGY trial substudy
file con accesso da definire2014 Campo, Gianluca Calogero; Punzetti, S; Malagù, M; Ferrari, Roberto; Valgimigli, M.
Understanding ARNIs
2019 Ferrari, R.; Silva-Cardoso, J.; Fonseca, M. C.
Understanding the results of the PARAGON-HF trial
2020 Ferrari, Roberto; Fucili, Alessandro; Rapezzi, Claudio
Uric acid and coronary artery disease: An elusive link deserving further attention
2016 Biscaglia, Simone; Ceconi, Claudio; Malagu', Michele; Pavasini, Rita; Ferrari, Roberto
Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry
2015 Fauchier, Laurent; Greenlaw, Nicola; Ferrari, Roberto; Ford, Ian; Fox, Kim M.; Tardif, Jean Claude; Tendera, Michal; Steg, P. h. Gabriel; Sokn, Fernando José; Reid, Christopher; Lang, Irene; Van Den Branden, Frank; César, Luis Machado; Mattos, Marco Antonio; Luqman, H. j. Nazar; Goudev, Assen; Dorian, Paul; Hu, Dayi; Widimsky, Petr; Hassager, Christian; Danchin, Nicolas; Kääb, Stefan; Vardas, Panos; Sulaiman, Kadhim J.; Al Mahmeed, Wael; Al Suwaidi, Jassim; Al Rashdan, Ibrahim; Abdulkader, Fuad; Merkely, Béla; Kaul, Upendra; Daly, Kieran; Tavazzi, Luigi; Jang, Yangsoo; Erglis, Andrejs; Laucevičius, Aleksandras; Jamaluddin, Ahmad Nizar; Gamba, Marco Alcocer; Tulevski, Igor I.; Stępińska, Janina; Morais, Joao; Macarie, Cezar; Oganov, Rafael; Shalnova, Svetlana; Al Zaibag, Muayed; Hou, Mak Koon; Kamensky, Gabriel; Fras, Zlatko; Kanič, Vojko; Naidoo, Datshana Prakesh; Zamorano, José Luis; Rickli, Hans; Jaussi, Andres; Sriratanasathavorn, Charn; Kalra, Paul; Lutai, Mykhailo; Oleksandr, Null; Nguyen, Lan Viet; Henry, Ronald
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Trimetazidine in cardiovascular medicine | 2019 | Marzilli, M.; Vinereanu, D.; Lopaschuk, G.; Chen, Y.; Dalal, J. J.; Danchin, N.; Etriby, E.; Ferr...ari, R.; Gowdak, L. H.; Lopatin, Y.; Milicic, D.; Parkhomenko, A.; Pinto, F.; Ponikowski, P.; Seferovic, P.; Rosano, G. M. C. | |
| Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium? | 1998 | Ceconi, Claudio; S., Curello; T., Bachetti; A., Corti; Ferrari, Roberto | file con accesso da definire |
| Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study. | 2005 | Marco, Valgimigli; Ceconi, Claudio; Malagutti, Patrizia; Elisa, Merli; Olga, Soukhomovskaia; Glor...ia, Francolini; Giordano, Cicchitelli; Adriana, Olivares; Giovanni, Parrinello; Gianfranco, Percoco; Gabriele, Guardigli; Donato, Mele; Roberto, Pirani; Ferrari, Roberto | file con accesso da definire |
| Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial | 2007 | Valgimigli, M; Bolognese, L; Anselmi, M; Campo, Gianluca Calogero; Rodriguez, Ae; de Cesare, N; C...ohen, Dj; Sheiban, I; Colangelo, S; Pasquetto, G; Hamon, M; Vranckx, P; Ferrario, M; Prati, F; Agostoni, P; Malagutti, P; Arcozzi, C; Parrinello, G; Vassanelli, C; Ferrari, Roberto; Percoco, G. | |
| Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study | 2007 | Valgimigli, M; Campo, Gianluca Calogero; Arcozzi, C; Malagutti, P; Carletti, R; Ferrari, F; Barbi...eri, D; Parrinello, G; Percoco, G; Ferrari, Roberto | |
| Two-year outcomes after first- or second-generation drug-eluting stent implantation in patients with in-stent restenosis. A PRODIGY trial substudy | 2014 | Campo, Gianluca Calogero; Punzetti, S; Malagù, M; Ferrari, Roberto; Valgimigli, M. | file con accesso da definire |
| Understanding ARNIs | 2019 | Ferrari, R.; Silva-Cardoso, J.; Fonseca, M. C. | |
| Understanding the results of the PARAGON-HF trial | 2020 | Ferrari, Roberto; Fucili, Alessandro; Rapezzi, Claudio | |
| Uric acid and coronary artery disease: An elusive link deserving further attention | 2016 | Biscaglia, Simone; Ceconi, Claudio; Malagu', Michele; Pavasini, Rita; Ferrari, Roberto | |
| Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry | 2015 | Fauchier, Laurent; Greenlaw, Nicola; Ferrari, Roberto; Ford, Ian; Fox, Kim M.; Tardif, Jean Claud...e; Tendera, Michal; Steg, P. h. Gabriel; Sokn, Fernando José; Reid, Christopher; Lang, Irene; Van Den Branden, Frank; César, Luis Machado; Mattos, Marco Antonio; Luqman, H. j. Nazar; Goudev, Assen; Dorian, Paul; Hu, Dayi; Widimsky, Petr; Hassager, Christian; Danchin, Nicolas; Kääb, Stefan; Vardas, Panos; Sulaiman, Kadhim J.; Al Mahmeed, Wael; Al Suwaidi, Jassim; Al Rashdan, Ibrahim; Abdulkader, Fuad; Merkely, Béla; Kaul, Upendra; Daly, Kieran; Tavazzi, Luigi; Jang, Yangsoo; Erglis, Andrejs; Laucevičius, Aleksandras; Jamaluddin, Ahmad Nizar; Gamba, Marco Alcocer; Tulevski, Igor I.; Stępińska, Janina; Morais, Joao; Macarie, Cezar; Oganov, Rafael; Shalnova, Svetlana; Al Zaibag, Muayed; Hou, Mak Koon; Kamensky, Gabriel; Fras, Zlatko; Kanič, Vojko; Naidoo, Datshana Prakesh; Zamorano, José Luis; Rickli, Hans; Jaussi, Andres; Sriratanasathavorn, Charn; Kalra, Paul; Lutai, Mykhailo; Oleksandr, Null; Nguyen, Lan Viet; Henry, Ronald |
Legenda icone
- file ad accesso aperto
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 03 Contributo in rivista (Pubblic... 575
- 03 Contributo in rivista (Pubblic... 575
- 04 Atto di Convegno (Proceedings) 41
- 04 Atto di Convegno (Proceedings)... 28
- 01 Libro 13
- 01 Libro::01.1 Monografia o Tratt... 13
- 02 Contributo in volume 7
- 02 Contributo in volume::02.1 Con... 7
- 04 Atto di Convegno (Proceedings)... 7
- 04 Atto di Convegno (Proceedings)... 6
- 08 Attività collegate alla Ricerca 3
- 08 Attività collegate alla Ricerc... 3
- 06 Brevetto 2
- 06 Brevetto::06.1 Brevetto 2
Data di pubblicazione
- 2020 - 2024 59
- 2010 - 2019 277
- 2000 - 2009 216
- 1990 - 1999 63
- 1985 - 1989 26
Editore
- Harcourt Publishers Limited:Foots... 4
- Attuale:ELSEVIER SCIENCE INC, 360... 3
- Servier 3
- Springer 3
- Lippincott, Williams & Wilkins:53... 2
- Mosby Year Book Incorporated:6277... 2
- Società Italiana di Cardiologia 2
- V.Brusasco 2
- Accademia Nazionale di Medicina 1
- Amal Kumar Banarjee 1
Rivista
- EUROPEAN HEART JOURNAL 75
- JOURNAL OF THE AMERICAN COLLEGE O... 29
- INTERNATIONAL JOURNAL OF CARDIOLOGY 28
- EUROPEAN HEART JOURNAL SUPPLEMENTS 27
- JOURNAL OF MOLECULAR AND CELLULAR... 27
- EUROPEAN JOURNAL OF HEART FAILURE 19
- CARDIOVASCULAR DRUGS AND THERAPY 18
- CIRCULATION 13
- AMERICAN HEART JOURNAL 10
- GIORNALE ITALIANO DI CARDIOLOGIA 10
Serie
- ADVANCES IN EXPERIMENTAL MEDICINE... 2
- ADVANCES IN CARDIOLOGY 1
- ADVANCES IN EXPERIMENTAL MEDICINE... 1
Keyword
- Cardiology and Cardiovascular Med... 63
- Humans 44
- Heart failure 27
- Male 24
- Female 23
- Aged 19
- Coronary artery disease 19
- Medicine (all) 19
- COVID-19 15
- Middle Aged 15
Lingua
- eng 612
- ita 26
- spa 1
Accesso al fulltext
- no fulltext 463
- open 93
- reserved 67
- partially open 18